Tvardi Therapeutics, Inc. (TVRD) AI Dilution Summary

Cash was $15,765,000 at 2026-06-30 against estimated monthly burn of $3,076,000. The company is funding itself through its ATM program with JonesTrading Institutional Services LLC, authorised to $20,736,315, with $13,346,550 sold and 3,957,599 shares sold since the program began through 2026-08-11; sales after 2026-08-11 are not yet reported.